Glibenclamide or glyburide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM) It was discovered in 1969 and approved for medical use in the united states in 1984. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Drug Class : Hypoglycemics ;Sulfonylureas Indications : Diabetes mellitus, type 2 SIDE EFFECTS : Hypoglycemia, Angioedema, Weight gain etc.